| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Actinium Pharmaceuticals, Inc. (ATNM) has 1 insider with recent SEC Form 4 filings, including 4 buys and 0 sells. ATNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 184.5K | $241.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2016 | Steinhart Richard I87 | Director | Buy | 2,500 | $2.01 | $5,025.00 | New | |
| Apr 14, 2016 | Dave Kaushik J | CEO And Interim CFO | Buy | 10,000 | $2.02 | $20,180.00 | +6.1% | |
| Apr 14, 2016 | Nicholson, C. David | Director | Buy | 5,000 | $2.00 | $10,000.00 | +50.0% |